Psychiatry and Neurology, Neurology · Weston, FL
NPI
1356354344
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
2950 Cleveland Clinic Blvd
Weston, FL, 33331
Phone (954) 659-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$103K
6,706 services
Medicare patients, 2024
422
Average age 76
Drug cost, 2024
$1.3M
3,688 prescriptions
Company payments, 2025
$862
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tarannum S Khan was code J0585 (injection, onabotulinumtoxina, 1 unit), 5,300 times for 14 patients. In total Tarannum S Khan billed 6,706 services in 27 codes, and Medicare paid $103K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 5,300 | 14 | $4.95 | $26K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 229 | 168 | $13.54 | $3,101 |
| 99214 Office E&M - Established | Facility | 226 | 174 | $71.81 | $16K |
| 99214 Office E&M - Established | Office | 102 | 84 | $90.64 | $9,245 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 81 | 71 | $13.55 | $1,097 |
| 99213 Office E&M - Established | Facility | 51 | 47 | $47.08 | $2,401 |
| 95984 Electrical Nerve Conductivity | Facility | 47 | 19 | $35.13 | $1,651 |
| 95874 Musculoskeletal | Facility | 47 | 20 | $15.09 | $709 |
| 99205 Office E&M - New | Facility | 45 | 45 | $145.49 | $6,547 |
| 95983 Electrical Nerve Conductivity | Facility | 41 | 20 | $39.81 | $1,632 |
| 64616 Musculoskeletal | Facility | 40 | 18 | $126.04 | $5,042 |
| 99205 Office E&M - New | Office | 39 | 39 | $170.86 | $6,663 |
| 99213 Office E&M - Established | Office | 34 | 28 | $65.26 | $2,219 |
| 64615 Musculoskeletal | Facility | 28 | 19 | $108.15 | $3,028 |
| 99204 Office E&M - New | Facility | 22 | 22 | $90.01 | $1,980 |
By year: 2022 $263K for 32,555 services; 2023 $272K for 35,749 services; 2024 $103K for 6,706 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tarannum S Khan prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 790 prescriptions and refills. In total Tarannum S Khan wrote 3,688 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 790 | 1,797 | 244 | $21K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 229 | 498 | 77 | $11K |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 181 | 463 | 62 | $3,490 |
| Gabapentin Generic | 143 | 259 | 58 | $1,506 |
| Primidone Generic | 137 | 342 | 43 | $3,242 |
| Clonazepam Generic | 121 | 170 | 41 | $530 |
| Propranolol Hcl Generic | 121 | 277 | 45 | $1,642 |
| Donepezil Hcl Generic | 120 | 296 | 52 | $1,006 |
| Ropinirole Hcl Generic | 116 | 272 | 35 | $2,942 |
| Carbidopa-Levodopa-Entacapone Carbidopa/Levodopa/Entacapone | 107 | 222 | 34 | $26K |
| Rytary Carbidopa/Levodopa | 93 | 175 | 24 | $85K |
| Amantadine Amantadine Hcl | 86 | 182 | 36 | $3,644 |
| Mirtazapine Generic | 84 | 159 | 31 | $1,001 |
| Topiramate Generic | 79 | 160 | 34 | $530 |
| Rivastigmine Rivastigmine Tartrate | 78 | 123 | 22 | $3,990 |
Brand drugs: 491 claims; generic drugs: 3,197 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tarannum S Khan $862 ($862 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $378.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 22 | $378 |
| MDD US Operations, LLC | 5 | $89.5 |
| Pfizer Inc. PFE | 4 | $76.67 |
| Lilly USA, LLC LLY | 2 | $46.88 |
| EMD Serono, Inc. MRK.DE | 2 | $41.69 |
| Merz Pharmaceuticals, LLC | 2 | $33.58 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $33.23 |
| Lungpacer Medical USA Inc | 1 | $30.91 |
| Medtronic, Inc. MDT | 1 | $27.3 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $27.08 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.